Cases of cervical cancer increase in Cali – Cali – Colombia

Cervical cancer, one of the most prevalent in Cali, is a silent enemy that is on the rise.

According to the district Health Secretary, in the last year, this disease had an increase of 73.9 percent compared to 2020. That means that two years ago a little more than a hundred cases were registered and the growth passed to more than double.

(Also read: The Attorney General opens an investigation into the mayor of Cali for Christmas lighting)

In turn, there were more cases of breast cancer during 2021 compared to 2020. In the Valle del Cauca capital, cut to the last epidemiological week of 2021, 731 cases of breast cancer were registered, an increase of 49.7 percent compared to to 2020.

“We have been working and doing an epidemiological analysis of the burden of the disease around this issue,” said the Secretary of Health of Cali, Miyerlandi Torres.

“It was identified that the diagnosis of breast and cervical cancer has increased above 73 percent, comparing the figures for 2021 with 2020. Likewise, it is above 30 percent of identified cases compared to the figures we had been managing. in 2019”, said the official.

(Also: Follow the alert for femicides in Cali and the Valley)

He added that the human papillomavirus (HPV) vaccine is a fundamental tool to prevent the onset of cervical or cervical cancer and is included in the Expanded Program on Immunization (EPI) in the country. He said it is free for minors between the ages of 9 and 17.

(Also read: Rejection for the murder of a girl in the north of the Valley)

The scheme consists of a first application and a booster dose at six months.

“HPV is part of a family of more than 200 viruses that attack humans. Of those, there are about 12 or 14 that are oncogenic, that is, they can produce tumors and malignant tumors,” explains pathologist Héctor Espinosa.

CALI

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Never miss any important news. Subscribe to our newsletter.